Detalles de la búsqueda
1.
The challenges inherent with anchor-based approaches to the interpretation of important change in clinical outcome assessments.
Qual Life Res;
32(5): 1239-1246, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396874
2.
Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata.
Qual Life Res;
32(5): 1319-1327, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35821174
3.
Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
Eur J Haematol;
109(3): 226-237, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35569114
4.
Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials.
Value Health;
25(7): 1090-1098, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35379564
5.
Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.
Headache;
61(3): 511-526, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33481276
6.
The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
J Investig Dermatol Symp Proc;
20(1): S71-S77, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33099392
7.
Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
Headache;
59(5): 756-774, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30861580
8.
Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis.
Health Qual Life Outcomes;
15(1): 239, 2017 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29212515
9.
Psychometric properties of the single-item measure, severity of worst tiredness, in patients with moderately to severely active rheumatoid arthritis.
Health Qual Life Outcomes;
15(1): 237, 2017 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29208004
10.
Evaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria.
Value Health;
18(4): 404-12, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26091594
11.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Mult Scler;
20(13): 1753-60, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740371
12.
Is Rasch model analysis applicable in small sample size pilot studies for assessing item characteristics? An example using PROMIS pain behavior item bank data.
Qual Life Res;
23(2): 485-93, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23912855
13.
Are treatment benefits in neuropathic pain reflected in the Self Assessment of Treatment questionnaire?
Health Qual Life Outcomes;
11: 8, 2013 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23332037
14.
The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition.
Qual Life Res;
22(2): 351-60, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22403040
15.
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.
Qual Life Res;
22(8): 1889-905, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23288613
16.
Association of Tafamidis With Health Status in Patients With ATTR Cardiac Amyloidosis: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial.
JAMA Cardiol;
8(3): 275-280, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36723935
17.
Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata.
Dermatol Ther (Heidelb);
12(1): 149-166, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34846634
18.
A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures.
Dermatol Ther (Heidelb);
12(8): 1907-1924, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35857279
19.
Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials.
Orphanet J Rare Dis;
17(1): 182, 2022 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35525989
20.
Meaningful Changes in What Matters to Individuals with Vitiligo: Content Validity and Meaningful Change Thresholds of the Vitiligo Area Scoring Index (VASI).
Dermatol Ther (Heidelb);
12(7): 1623-1637, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773559